H. May

H. May, T. Bunch, J. Dimarco, 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Surgical Revascularization Is Associated With Improved Long-Term Outcomes Compared With Percutaneous Stenting in Most Subgroups of Patients With Multivessel Coronary Artery Disease: Results From the Intermountain Heart Registry

B. Horne, H. May, D. Lappé, 2007, Circulation.

High Statin Adherence over 5 Years of Follow-up is Associated with Improved Cardiovascular Outcomes in Patients with Atherosclerotic Cardiovascular Disease: Results from the IMPRES Study.

H. May, D. Lappé, T. Bair, 2021, European heart journal. Quality of care & clinical outcomes.

Coronary Artery Calcium Versus Pooled Cohort Equations Score for Primary Prevention Guidance: Randomized Feasibility Trial.

Kevin M. Johnson, H. May, D. Lappé, 2021, JACC. Cardiovascular imaging.

The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.

H. May, T. Bair, T. Bunch, 2017, The American journal of cardiology.

Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.

H. May, T. Bair, T. Bunch, 2016, The American journal of cardiology.

Lack of Association of Tegaserod With Adverse Cardiovascular Outcomes in a Matched Case-Control Study

B. Horne, H. May, J. Carlquist, 2009, Journal of cardiovascular pharmacology and therapeutics.

Relation of routine, periodic fasting to risk of diabetes mellitus, and coronary artery disease in patients undergoing coronary angiography.

B. Horne, H. May, D. Lappé, 2012, The American journal of cardiology.

Utility of high density lipoprotein particle concentration in predicting future major adverse cardiovascular events among patients undergoing angiography.

H. May, Jeffrey L. Anderson, M. Connelly, 2016, Clinical biochemistry.

Homocysteine Levels Are Associated with Increased Risk of Congestive Heart Failure in Patients with and without Coronary Artery Disease

B. Horne, H. May, D. Renlund, 2006, Cardiology.

Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility.

B. Horne, N. Camp, H. May, 2008, American heart journal.

Five‐Year Outcomes of Catheter Ablation in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction

H. May, T. Bair, Jeffrey L. Anderson, 2015, Journal of cardiovascular electrophysiology.

Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure.

H. May, Jeffrey L. Anderson, J. Muhlestein, 2009, American heart journal.

Potential benefits of eicosapentaenoic acid on atherosclerotic plaques.

M. Budoff, H. May, O. Wani, 2017, Vascular pharmacology.

Association of vitamin D levels with incident depression among a general cardiovascular population.

B. Horne, H. May, D. Lappé, 2010, American heart journal.

Safety and Efficacy of Periprocedural Heparin Plus a Short-Term Infusion of Tirofiban Versus Bivalirudin Monotherapy in Patients Who Underwent Percutaneous Coronary Intervention (from the Intermountain Heart Institute STAIR Observational Registry).

H. May, D. Lappé, T. Bair, 2019, The American journal of cardiology.

Relation of bisphosphonate therapies and risk of developing atrial fibrillation.

B. Horne, H. May, D. Lappé, 2009, The American journal of cardiology.

Augmented intelligence decision tool for stroke prediction combines factors from CHA2DS2‐VASc and the intermountain risk score for patients with atrial fibrillation

B. Horne, H. May, T. Bunch, 2019, Journal of cardiovascular electrophysiology.

Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?

B. Horne, H. May, D. Lappé, 2011, American heart journal.

A Strategy of Rapid Cardioversion Minimizes the Significance of Early Recurrent Atrial Tachyarrhythmias After Ablation for Atrial Fibrillation

H. May, D. Lappé, T. Bair, 2011, Journal of cardiovascular electrophysiology.

Intermountain chronic disease risk score (ICHRON) validation for prediction of incident chronic disease diagnoses in an australian primary prevention population.

B. Horne, H. May, Jeffrey L. Anderson, 2020, European journal of internal medicine.

Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial

Deepak L. Bhatt, M. Budoff, H. May, 2020, European heart journal.

Multi-institutional distributed data networks for real-world evidence about medical devices: building unique device identifiers into longitudinal data (BUILD)

H. May, J. Muhlestein, J. Graham, 2022, JAMIA open.

Incidence of Dementia in Relation to Genetic Variants at PITX2, ZFHX3, and ApoE ε4 in Atrial Fibrillation Patients

H. May, J. Carlquist, T. Bunch, 2015, Pacing and clinical electrophysiology : PACE.

Association of periodic fasting lifestyles with survival and incident major adverse cardiovascular events in patients undergoing cardiac catheterization.

Ciera L Bartholomew, B. Horne, H. May, 2020, European journal of preventive cardiology.

Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genes

B. Horne, H. May, J. Carlquist, 2013, Thrombosis and Haemostasis.

Long-Term Natural History of Adult Wolff–Parkinson–White Syndrome Patients Treated With and Without Catheter Ablation

H. May, T. Bair, Jeffrey L. Anderson, 2015, Circulation. Arrhythmia and electrophysiology.

GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study

H. May, D. Lappé, Jeffrey L. Anderson, 2018, American heart journal.

Pilot Study of Novel Intermittent Fasting Effects on Metabolomic and Trimethylamine N-oxide Changes During 24-hour Water-Only Fasting in the FEELGOOD Trial

B. Horne, H. May, J. Carlquist, 2019, Nutrients.

Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.

H. May, T. Bair, T. Bunch, 2014, Heart rhythm.

Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide.

D. Mozaffarian, B. Horne, H. May, 2007, The American journal of cardiology.

European Society of Cardiology: Cardiovascular Disease Statistics 2019 (Executive Summary).

G. Hindricks, S. Achenbach, H. May, 2020, European heart journal. Quality of care & clinical outcomes.

Preferential Metabolic Improvement by Intermittent Fasting in People with Elevated Baseline Red Cell Distribution Width: A Secondary Analysis of the WONDERFUL Randomized Controlled Trial

B. Horne, H. May, T. Bair, 2021, Nutrients.

Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).

B. Horne, H. May, R. Pearson, 2008, The American journal of cardiology.

Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study

M. Budoff, H. May, V. Le, 2018, Clinical cardiology.

Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients with Elevated Triglycerides on Statin Therapy: A prospective, placebo-controlled randomized trial (EVAPORATE): Interim Results.

Deepak L. Bhatt, M. Budoff, H. May, 2020, Cardiovascular research.

Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US Population

B. Horne, H. May, J. Muhlestein, 2021, JAMA network open.

Relation of elevated plasma renin activity at baseline to cardiac events in patients with angiographically proven coronary artery disease.

Richard D. White, B. Horne, H. May, 2010, The American journal of cardiology.

Abstract 1147: Vitamin D Deficiency is Strongly Associated With Incident Death and Cardiovascular Disease in a General Healthcare Population

B. Horne, H. May, Brianna S. Ronnow, 2009 .

Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure.

B. Horne, H. May, D. Renlund, 2006, The American journal of cardiology.

Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes.

H. May, D. Lappé, T. Bair, 2013, Heart rhythm.

Stroke and Dementia Risk in Patients with and without Atrial Fibrillation and Carotid Arterial Disease.

H. May, T. Bair, T. Bunch, 2019, Heart rhythm.

Ranolazine Reduces Ventricular Tachycardia Burden and ICD Shocks in Patients with Drug‐Refractory ICD Shocks

H. May, D. Lappé, T. Bair, 2011, Pacing and clinical electrophysiology : PACE.

Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19

H. May, T. Bair, M. Cutler, 2022, IJC Heart & Vasculature.

Practical laboratory-based clinical decision tools and associations with short-term bleeding and mortality outcomes.

B. Horne, H. May, D. Lappé, 2018, Clinica chimica acta; international journal of clinical chemistry.

Atrial Fibrillation Patients Treated With Long‐Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long‐Term Warfarin for Other Indications

H. May, T. Bair, T. Bunch, 2016, Journal of the American Heart Association.

A Small but Significantly Greater Incidence of Inflammatory Heart Disease Identified After Vaccination for Severe Acute Respiratory Syndrome Coronavirus 2

B. Horne, H. May, J. Muhlestein, 2021, Open forum infectious diseases.

A small but significantly greater incidence of inflammatory heart disease identified after vaccination for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)

B. Horne, H. May, K. Knowlton, 2021 .

Long‐term aspirin does not lower risk of stroke and increases bleeding risk in low‐risk atrial fibrillation ablation patients

H. May, T. Bair, T. Bunch, 2017, Journal of cardiovascular electrophysiology.

Atrial fibrillation: a risk factor or risk marker?

H. May, T. Bunch, 2016, European heart journal.

Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long‐Term Risk of Dementia

H. May, T. Bair, Jeffrey L. Anderson, 2015, Journal of cardiovascular electrophysiology.

Vitamin D supplementation protects against reductions in plasma 25‐hydroxyvitamin D induced by open‐heart surgery: Assess‐d trial

H. May, D. Lappé, J. Carlquist, 2021, Physiological reports.

Atrial fibrillation incrementally increases dementia risk across all CHADS2 and CHA2DS2VASc strata in patients receiving long‐term warfarin

H. May, T. Bair, M. Cutler, 2017, American heart journal.

Long-term Outcomes After Low Power, Slower Movement versus High Power, Faster Movement Irrigated-Tip Catheter Ablation for Atrial Fibrillation.

H. May, T. Bair, T. Bunch, 2020, Heart rhythm.

Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial

Ciera L Bartholomew, B. Horne, H. May, 2021, European heart journal open.

Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients with Elevated Triglycerides(200-499mg/dL)on Statin Therapy(EVAPORATE Study): Rationale and Design

M. Budoff, H. May, J. Muhlestein, 2017 .

Atrial Fibrillation Ablation and its Impact on Stroke

H. May, T. Bunch, M. Cutler, 2018, Current Treatment Options in Cardiovascular Medicine.

Abstract 13877: 5-Year Impact of Catheter Ablation for Atrial Fibrillation in Patients With a Prior History of Stroke

H. May, T. Bair, T. Bunch, 2016 .

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

GLYCA AND GLYCB, NOVEL NMR BIOMARKERS OF INFLAMMATION, STRONGLY PREDICT FUTURE CARDIOVASCULAR EVENTS, BUT NOT THE PRESENCE OF CORONARY ARTERY DISEASE (CAD), AMONG PATIENTS UNDERGOING CORONARY ANGIOGRAPHY: THE INTERMOUNTAIN HEART COLLABORATIVE STUDY

H. May, Jeffrey L. Anderson, M. Connelly, 2014 .

SUPPLEMENTING DEFICIENT VITAMIN D LEVELS IS ASSOCIATED WITH REDUCED CARDIOVASCULAR RISK

B. Horne, H. May, D. Lappé, 2010 .

Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.

H. May, D. Lappé, T. Bair, 2014, JAMA.

More Aggressive Left Atrial Ablation in Elderly Patients does not Increase Procedural Complications and Favorably Impacts Outcomes

H. May, D. Lappé, T. Bair, 2011 .

Long‐Term Clinical Efficacy and Risk of Catheter Ablation for Atrial Fibrillation in Octogenarians

H. May, D. Lappé, T. Bair, 2010, Pacing and clinical electrophysiology : PACE.

Warfarin Is Not Needed in Low‐Risk Patients Following Atrial Fibrillation Ablation Procedures

H. May, D. Lappé, T. Bair, 2009, Journal of cardiovascular electrophysiology.

Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease.

B. Horne, H. May, Brianna S. Ronnow, 2007, The American journal of cardiology.

Association of periodic fasting with lower severity of COVID-19 outcomes in the SARS-CoV-2 prevaccine era: an observational cohort from the INSPIRE registry

B. Horne, H. May, T. Bair, 2022, medRxiv.

Vagus nerve injury symptoms after catheter ablation for atrial fibrillation

H. May, T. Bunch, M. Cutler, 2018, Pacing and clinical electrophysiology : PACE.

Intracardiac Ultrasound for Esophageal Anatomic Assessment and Localization During Left Atrial Ablation for Atrial Fibrillation

H. May, D. Lappé, T. Bair, 2013, Journal of cardiovascular electrophysiology.

The utility of the apolipoprotein A1 remnant ratio in predicting incidence coronary heart disease in a primary prevention cohort: The Jackson Heart Study

B. Horne, H. May, J. Muhlestein, 2016, European journal of preventive cardiology.

Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography.

B. Horne, H. May, D. Lappé, 2008, The American journal of cardiology.

A Comparison of Remote Magnetic Irrigated Tip Ablation versus Manual Catheter Irrigated Tip Catheter Ablation With and Without Force Sensing Feedback

H. May, T. Bair, T. Bunch, 2016, Journal of cardiovascular electrophysiology.

The Impact of Age on 5‐Year Outcomes After Atrial Fibrillation Catheter Ablation

Michael Cutler, H. May, T. Bair, 2016, Journal of cardiovascular electrophysiology.

Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia.

B. Horne, H. May, D. Lappé, 2010, Heart rhythm.

Absent or Mild Coronary Calcium Predicts Low-Risk Stress Test Results and Outcomes in Patients Considered for Flecainide Therapy

H. May, T. Bunch, M. Cutler, 2021, Journal of cardiovascular pharmacology and therapeutics.

Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score.

H. May, D. Lappé, T. Bair, 2013, Heart rhythm.

The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints

B. Horne, H. May, Brianna S. Ronnow, 2010, European journal of heart failure.

Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation

H. May, T. Bair, T. Bunch, 2016, Journal of Interventional Cardiac Electrophysiology.

A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL3+IDL])

B. Horne, H. May, T. Bair, 2013, Lipids in Health and Disease.

Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population.

B. Horne, H. May, D. Lappé, 2010, The American journal of cardiology.

Free thyroxine within the normal reference range predicts risk of atrial fibrillation

H. May, D. Lappé, T. Bair, 2020, Journal of cardiovascular electrophysiology.

Long-term Outcomes in Patients Treated with Flecainide for Atrial Fibrillation with Stable Coronary Artery Disease.

H. May, T. Bair, T. Bunch, 2021, American heart journal.

Atrial Fibrillation and Dementia: Exploring the Association, Defining Risks and Improving Outcomes

H. May, T. Bunch, V. Jacobs, 2018, Arrhythmia & electrophysiology review.

CHA2DS2-VASc scores and Intermountain Mortality Risk Scores for the joint risk stratification of dementia among patients with atrial fibrillation.

B. Horne, H. May, D. Lappé, 2019, Heart rhythm.

Intermittent fasting and changes in Galectin-3: A secondary analysis of a randomized controlled trial of disease-free subjects.

B. Horne, H. May, T. Bair, 2022, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease.

B. Horne, H. May, J. Carlquist, 2013, The American journal of cardiology.

Randomized cross-over trial of short-term water-only fasting: metabolic and cardiovascular consequences.

B. Horne, H. May, D. Lappé, 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Both initial red cell distribution width (RDW) and change in RDW during heart failure hospitalization are associated with length of hospital stay and 30‐day outcomes

J. L. Anderson, B. Horne, H. May, 2016, International journal of laboratory hematology.

Panoptic total cardiovascular risk prediction using all predictors versus optimized risk assessment using variable subsets.

B. Horne, H. May, S. Knight, 2012, Future cardiology.

Antilipidemic adherence post-coronary artery disease diagnosis among those with and without an ICD-9 diagnosis of depression.

B. Horne, H. May, J. Carlquist, 2010, Journal of psychosomatic research.

Coronary artery plaque volume and obesity in patients with diabetes: the factor-64 study.

H. May, D. Lappé, Jeffrey L. Anderson, 2014, Radiology.

Mechanisms of Improved Mortality Following Ablation: Does Ablation Restore Beta-Blocker Benefit in Atrial Fibrillation/Heart Failure?

H. May, T. Bunch, K. Afshar, 2019, Cardiology clinics.

Improvement in the predictive ability of the Intermountain Mortality Risk Score by adding routinely collected laboratory tests such as albumin, bilirubin, and white cell differential count

B. Horne, H. May, Brianna S. Ronnow, 2016, Clinical chemistry and laboratory medicine.

trial fibrillation is independently associated with senile , ascular , and Alzheimer ’ s dementia

H. May, D. Lappé, Jeffrey L. Anderson, 2022 .

Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System.

H. May, D. Lappé, J. Carlquist, 2016, The American journal of cardiology.

Clinical predictors of risk for atrial fibrillation: implications for diagnosis and monitoring.

H. May, T. Bair, Jeffrey L. Anderson, 2014, Mayo Clinic proceedings.

Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies

J. Manson, H. May, Jeffrey L. Anderson, 2012, Circulation. Cardiovascular quality and outcomes.

Association of the dispersion in red blood cell volume with mortality

B. Horne, H. May, J. Muhlestein, 2015, European journal of clinical investigation.

Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population.

W. Kraus, B. Horne, H. May, 2011, Clinica chimica acta; international journal of clinical chemistry.

Relation of heart failure hospitalization to exposure to fine particulate air pollution.

C. Pope, B. Horne, H. May, 2008, The American journal of cardiology.

Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long‐term outcomes in patients with and without structural heart disease

H. May, M. Cutler, R. Ranjan, 2023, Journal of cardiovascular electrophysiology.

Depression after coronary artery disease is associated with heart failure.

B. Horne, H. May, J. Carlquist, 2009, Journal of the American College of Cardiology.

The association of depression at any time to the risk of death following coronary artery disease diagnosis

B. Horne, H. May, D. Lappé, 2017, European heart journal. Quality of care & clinical outcomes.

UTILITY OF HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL, PARTICLE CONCENTRATION, AND SIZE IN PREDICTING FUTURE MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG PATIENTS UNDERGOING ANGIOGRAPHY: THE INTERMOUNTAIN HEART COLLABORATIVE STUDY

H. May, Jeffrey L. Anderson, M. Connelly, 2014 .

Real-world clinical burden and economic assessment associated with hyperkalaemia in a large integrated healthcare system: a retrospective analysis

H. May, D. Lappé, T. Bair, 2021, BMC Primary Care.

Effect of work-hour restriction on operative experience in cardiothoracic surgical residency training.

H. May, D. Bull, R. Robbins, 2009, The Journal of thoracic and cardiovascular surgery.

Trends in early and late mortality in patients undergoing coronary catheterization for myocardial infarction: implications on observation periods and risk factors to determine ICD candidacy.

B. Horne, H. May, D. Lappé, 2011, Heart rhythm.

Abstract 14708: Pradaxa Can Be Safely Used As Monotherapy Or As A Bridge To Therapeutic Warfarin After Atrial Fibrillation Ablation

H. May, T. Bunch, J. Day, 2011 .

Economics and outcomes of sotalol in‐patient dosing approaches in patients with atrial fibrillation

H. May, T. Bair, J. Muhlestein, 2021, Journal of cardiovascular electrophysiology.

ECONOMICS OF SOTALOL IN-PATIENT DOSING APPROACHES IN PATIENTS WITH ATRIAL FIBRILLATION

H. May, T. Bair, Jeffrey L. Anderson, 2020 .

Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.

B. Horne, H. May, D. Renlund, 2006, American heart journal.

Association of Rhesus factor blood type with risk of SARS‐CoV‐2 infection and COVID‐19 severity

B. Horne, H. May, T. Bair, 2022, British Journal of Haematology.

Genome-Wide Significance and Replication of the Chromosome 12p11.22 Locus Near the PTHLH Gene for Peripartum Cardiomyopathy

B. Horne, H. May, J. Muhlestein, 2011, Circulation. Cardiovascular genetics.

Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia.

H. May, T. Bair, Jeffrey L. Anderson, 2014, Heart rhythm.

Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [CAF] trial)

H. May, T. Bunch, M. Cutler, 2022, Journal of arrhythmia.

Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study

H. May, T. Bunch, M. Cutler, 2019, Clinical cardiology.

Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial.

B. Horne, H. May, D. Lappé, 2021, American heart journal.

Rapid melting curve analysis for genetic variants that underlie inter-individual variability in stable warfarin dosing

B. Horne, H. May, J. Carlquist, 2008, Journal of Thrombosis and Thrombolysis.

Frequency and Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction (NSTEMI) without Standard Modifiable Risk Factors: A US Healthcare Experience

H. May, T. Bair, J. Muhlestein, 2023, Journal of clinical medicine.

Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare Experience

H. May, T. Bair, J. Muhlestein, 2022, Journal of clinical medicine.

Multimarkers of metabolic malnutrition and inflammation and their association with mortality risk in cardiac catheterisation patients: a prospective, longitudinal, observational, cohort study.

W. Kraus, H. May, J. Muhlestein, 2023, The lancet. Healthy longevity.

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.

Michael I. Jordan, Jasmine A. Berry, Mollie R. Cummins, 2023, JAMA.

The association of antidepressant and statin use with death and incident cardiovascular disease varies by depression severity

B. Horne, H. May, T. Bair, 2017, Psychology, health & medicine.

The Impact of Gender on Atrial Fibrillation Incidence and Progression to Dementia.

H. May, T. Bair, T. Bunch, 2018, The American journal of cardiology.

Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?

B. Horne, H. May, J. Carlquist, 2007, American heart journal.

Predictors of Statin Intolerance in Patients with a New Diagnosis of Atherosclerotic Cardiovascular Disease Within a Large Integrated Healthcare Institution: The IMPRES Study.

H. May, D. Lappé, T. Bair, 2020, Journal of cardiovascular pharmacology.

Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease-Real-world experience within a large integrated health care system: The IMPRES study.

H. May, D. Lappé, T. Bair, 2018, Journal of clinical lipidology.

Repeated Measurement of the Intermountain Risk Score Enhances Prognostication for Mortality

Benjamin D. Horne, Donald L. Lappé, Deborah Budge, 2013, PloS one.

Depression as a Driving Force for Low Time in Therapeutic Range and Dementia in Patients With and Without Atrial Fibrillation.

H. May, T. Bair, Jeffrey L. Anderson, 2021, The American journal of cardiology.

INCIDENCE OF DEMENTIA IN RELATION TO GENETIC VARIANTS AT 4Q25 AND APOE ɛ4 IN ATRIAL FIBRILLATION PATIENTS

H. May, J. Carlquist, Jeffrey L. Anderson, 2013 .

Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design

Michael I. Jordan, David E. Warren, David W. Chestek, 2023, medRxiv.

Frequency and clinical impact of hyperkalaemia within a large, modern, real‐world heart failure population

H. May, D. Lappé, T. Bair, 2020, ESC heart failure.

Five‐year impact of catheter ablation for atrial fibrillation in patients with a prior history of stroke

H. May, T. Bair, T. Bunch, 2018, Journal of cardiovascular electrophysiology.

Genome-wide Significance and Replication of the Chromosome 12 p 11 . 22 Locus Near the PTHLH Gene for Peripartum Cardiomyopathy Running title : Horne et al . ; Chromosome 12 p 11 . 22 for Peripartum Cardiomyopathy

B. Horne, H. May, J. Muhlestein, 2011 .

Fasting and other health influences.

B. Horne, H. May, D. Lappé, 2009, The American journal of cardiology.

Improving CHA2DS2-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation

B. Horne, H. May, D. Lappé, 2018, Open Heart.

Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortality.

B. Horne, H. May, J. Muhlestein, 2018, JCI insight.

Patients Treated with Catheter Ablation for Atrial Fibrillation have Long-Term Renal Function Similar to Patients without Atrial Fibrillation

H. May, T. Bair, Jeffrey L. Anderson, 2014 .

Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events

B. Horne, H. May, J. Carlquist, 2023, Frontiers in cardiovascular medicine.

EFFECT OF ANTIHYPERTENSIVE CLASS ON VISIT-TO-VISIT OFFICE BLOOD PRESSURE VARIABILITY AND ITS EFFECT ON ALL-CAUSE MORTALITY

B. Horne, H. May, J. Muhlestein, 2018 .

Association of the Intermountain Risk Score with major adverse health events in patients positive for COVID-19: an observational evaluation of a US cohort

B. Horne, H. May, Brianna S. Ronnow, 2022, BMJ Open.

The intermountain risk score predicts incremental age-specific long-term survival and life expectancy.

Deborah Budge, Rami Alharethi, B. Horne, 2011, Translational research : the journal of laboratory and clinical medicine.

Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies

J. Manson, H. May, Jeffrey L. Anderson, 2012, Circulation. Cardiovascular quality and outcomes.

Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.

H. May, D. Lappé, T. Bair, 2014, JAMA.

H. May, T. Bair, T. Bunch, 2014, Heart rhythm.

Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?

B. Horne, H. May, D. Lappé, 2011, American heart journal.

Relation of heart failure hospitalization to exposure to fine particulate air pollution.

C. Pope, B. Horne, H. May, 2008, The American journal of cardiology.

Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortality.

B. Horne, H. May, J. Muhlestein, 2018, JCI insight.

ASSOCIATION BETWEEN BASELINE PLASMA RENIN ACTIVITY AND CLINICAL OUTCOMES IN NON-HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE: PP.24.458

B. Horne, H. May, T. Bair, 2010 .

Abstract 1133: Association Between Baseline Plasma Renin Activity and Risk of Cardiovascular Events in Women With Coronary Artery Disease

B. Horne, H. May, T. Bair, 2009 .

Common and Rare Variant Contributions to Bradyarrhythmias from Multi-Ancestry Meta-Analyses

K. Lunetta, H. May, P. Ellinor, 2023, medRxiv.

Warfarin Is Not Needed in Low‐Risk Patients Following Atrial Fibrillation Ablation Procedures

H. May, D. Lappé, T. Bair, 2009, Journal of cardiovascular electrophysiology.

Atrial Fibrillation and Dementia: Exploring the Association, Defining Risks and Improving Outcomes

H. May, Kevin G. Graves, O. Galenko, 2018, Arrhythmia & electrophysiology review.

Abstract 13426: Percent Time With a Supratherapeutic Inr in Atrial Fibrillation Patients Using an Antiplatelet Agent is Associated With Long-term Risk of Dementia

H. May, T. Bair, Jeffrey L. Anderson, 2014 .

Depression after coronary artery disease is associated with heart failure.

B. Horne, H. May, J. Carlquist, 2009, Journal of the American College of Cardiology.

The Impact of Repeated Cardioversions for Atrial Fibrillation on Stroke, Hospitalizations, and Catheter Ablation Outcomes

H. May, T. Bair, T. Bunch, 2019 .

HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative.

P. Joshi, H. May, Jeffrey L. Anderson, 2015, European heart journal.

Utility of high density lipoprotein particle concentration in predicting future major adverse cardiovascular events among patients undergoing angiography.

H. May, Jeffrey L. Anderson, M. Connelly, 2016, Clinical biochemistry.

Long-Term Natural History of Adult Wolff–Parkinson–White Syndrome Patients Treated With and Without Catheter Ablation

H. May, T. Bair, M. Cutler, 2015, Circulation. Arrhythmia and electrophysiology.

Quantitative imaging biomarkers of coronary plaque morphology: insights from EVAPORATE

P. Libby, H. May, J. Muhlestein, 2023, Frontiers in cardiovascular medicine.

B. Horne, H. May, D. Lappé, 2007, Circulation.